Claudia Maria Hattinger

8PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone Metastasis.

Veronica Giusti, Leonardo Fantoni, Monica Torsello

|May 13, 2025
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.

Dimas Carolina Belisario, Muhlis Akman, Martina Godel

|Nov 27, 2024
The Interplay Between the MYC Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets.

Ania Naila Guerrieri, Claudia Maria Hattinger, Federica Marchesini

|Aug 29, 2024
Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research.

Veronica Giusti, Giacomo Miserocchi, Giulia Sbanchi

|Jan 08, 2023
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.

Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni

|Oct 14, 2022
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.

Claudia Maria Hattinger, Chiara Casotti, Maria Pia Patrizio

Pageof 2

Frequent Collaborators

7 joint publications

Massimo Serra

5 joint publications

Toni Ibrahim

4 joint publications

Chiara Riganti

4 joint publications

Leonardo Fantoni